Erector Spinae vs Fascia Iliaca Block in Hip Arthroplasty
NCT ID: NCT03860324
Last Updated: 2021-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-04-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Since then, there have been reports about the successful use of this block for bariatric surgery, ventral hernia repair, radical mastectomy, rib fractures, major abdominal surgery and hip replacement. However, there are no studies in the literature comparing the efficacy of the ESP block to other nerve blocks.
The purpose of this study is to compare the post-operative analgesic efficacy of the ESP block to the fascia iliaca (FI) block after total hip replacement (THR).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lumbar Erector Spinae Plane Block: Cadaveric Study
NCT04166188
Regional Anesthesia in THR - Comparing the Analgesic Efficacy of Fascia Iliaca Block and Erector Spinae Plane Block
NCT04574154
Erector Spinae Block Versus PENG Block for Hip Replacement
NCT05796804
Comparative Assessment of Effectiveness and Safety of L-ESPB Versus Absence of Locoregional Block in Hip Surgery
NCT06567522
Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy
NCT04917510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control-group
No peripheral nerve block
No interventions assigned to this group
Single-shot erector spinae plane block
The patient is positioned in lateral decubitus. The anesthesiologist uses a linear high-frequency probe in a longitudinal direction laterally to the mid-sagittal plane at the level of L4 until the transverse process is identified and, more superficial, the erector spinae muscle. A 22G needle of 80mm is introduced in-plane craniocaudally towards the transverse process of L4 until its tip is in the plane deep to the erector spinae muscle. Single-shot block with 30ml of ropivacaine 0,5% + adrenaline 100mcg
Single-shot erector spinae plane block
Single-shot Erector Spinae Plane block with 30ml of ropivacaine 0,5% + adrenaline 150mcg.
Single-shot fascia iliaca block
The patient is positioned in dorsal decubitus. The anesthesiologist uses a linear high-frequency probe in a transversal direction, below the crural arch so as to identify the femoral artery. Afterwards the probe is moved laterally to find the iliac muscle and its fascia. A 22G needle of 80mm is introduced in-plane latero-medially until its tip is below the fascia iliaca (between the muscle and its fascia). Single-shot block with 40ml of ropivacaine 0,2%.
Single-shot fascia iliaca block
Single-shot Fascia Iliaca block with 40ml of ropivacaine 0,2%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single-shot erector spinae plane block
Single-shot Erector Spinae Plane block with 30ml of ropivacaine 0,5% + adrenaline 150mcg.
Single-shot fascia iliaca block
Single-shot Fascia Iliaca block with 40ml of ropivacaine 0,2%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signing of consent form to participate in the study
Exclusion Criteria
* BMI \> 40 kg/m2
* Surgical plan for revision of hip replacement
* Patient unable to quantify pain level
* Chronic kidney disease with a Glomerular Filtration Rate \< 50ml/min
* Previously medicated with opioids
* Patient unable to perform the surgery with spinal block
* Allergy to local anesthetics
* Infection in the site of the Erector Spinae Plane or Fascia Iliaca block
* Allergy or contraindication to the use of morphine
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Beatriz Ângelo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
André Carrão
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
André Carrão
Role: PRINCIPAL_INVESTIGATOR
Hospital Beatriz Ângelo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Beatriz Ângelo
Loures, Lisbon District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
45149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.